both tachycardia and bradycardia occurred during infusion of prostacyclin , but 6-oxo-prostaglandin f1alpha ( infused at 10 micrograms.kg-1.min-1 ) , the stable degradation produce of prostacyclin , had no cardiovascular effects .
C0428977
bradycardia
C0007226
cardiovascular